Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Name: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

alk-positive large b-cell lymphoma, diffuse large b-cell lymphoma activated b-cell type, diffuse large b-cell lymphoma associated with chronic inflammation, diffuse large b-cell lymphoma germinal center b-cell type, diffuse large b-cell lymphoma, not otherwise specified, ebv-positive diffuse large b-cell lymphoma, not otherwise specified

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 356466
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.